Membrane Disruption by Antimicrobial Fatty Acids Releases Low-Molecular-Weight Proteins from Staphylococcus aureus
- 1 October 2012
- journal article
- research article
- Published by American Society for Microbiology in Journal of Bacteriology
- Vol. 194 (19), 5294-5304
- https://doi.org/10.1128/jb.00743-12
Abstract
The skin represents an important barrier for pathogens and is known to produce fatty acids that are toxic toward Gram-positive bacteria. A screen of fatty acids as growth inhibitors of Staphylococcus aureus revealed structure-specific antibacterial activity. Fatty acids like oleate (18:1Δ9) were nontoxic, whereas palmitoleate (16:1Δ9) was a potent growth inhibitor. Cells treated with 16:1Δ9 exhibited rapid membrane depolarization, the disruption of all major branches of macromolecular synthesis, and the release of solutes and low-molecular-weight proteins into the medium. Other cytotoxic lipids, such as glycerol ethers, sphingosine, and acyl-amines blocked growth by the same mechanisms. Nontoxic 18:1Δ9 was used for phospholipid synthesis, whereas toxic 16:1Δ9 was not and required elongation to 18:1Δ11 prior to incorporation. However, blocking fatty acid metabolism using inhibitors to prevent acyl-acyl carrier protein formation or glycerol-phosphate acyltransferase activity did not increase the toxicity of 18:1Δ9, indicating that inefficient metabolism did not play a determinant role in fatty acid toxicity. Nontoxic 18:1Δ9 was as toxic as 16:1Δ9 in a strain lacking wall teichoic acids and led to growth arrest and enhanced release of intracellular contents. Thus, wall teichoic acids contribute to the structure-specific antimicrobial effects of unsaturated fatty acids. The ability of poorly metabolized 16:1 isomers to penetrate the cell wall defenses is a weakness that has been exploited by the innate immune system to combat S. aureus .Keywords
This publication has 53 references indexed in Scilit:
- Antibacterial Activity of Sphingoid Bases and Fatty Acids against Gram-Positive and Gram-Negative BacteriaAntimicrobial Agents and Chemotherapy, 2012
- Metabolic basis for the differential susceptibility of Gram-positive pathogens to fatty acid synthesis inhibitorsProceedings of the National Academy of Sciences of the United States of America, 2011
- Differential Target Gene Activation by the Staphylococcus aureus Two-Component System saeRSJournal of Bacteriology, 2010
- Expression of Vibrio harveyi Acyl-ACP Synthetase Allows Efficient Entry of Exogenous Fatty Acids into the Escherichia coli Fatty Acid and Lipid A Synthetic PathwaysBiochemistry, 2009
- Waves of resistance: Staphylococcus aureus in the antibiotic eraNature Reviews Microbiology, 2009
- Telavancin Disrupts the Functional Integrity of the Bacterial Membrane through Targeted Interaction with the Cell Wall Precursor Lipid IIAntimicrobial Agents and Chemotherapy, 2009
- Wall Teichoic Acid Protects Staphylococcus aureus against Antimicrobial Fatty Acids from Human SkinJournal of Bacteriology, 2009
- Wall Teichoic Acid Deficiency inStaphylococcus aureusConfers Selective Resistance to Mammalian Group IIA Phospholipase A2and Human β-Defensin 3Infection and Immunity, 2008
- Lesions in Teichoic Acid Biosynthesis in Staphylococcus aureus Lead to a Lethal Gain of Function in the Otherwise Dispensable PathwayJournal of Bacteriology, 2006
- The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophageNature, 1983